These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval. Breitbach CJ; Reid T; Burke J; Bell JC; Kirn DH Cytokine Growth Factor Rev; 2010; 21(2-3):85-9. PubMed ID: 20472490 [TBL] [Abstract][Full Text] [Related]
6. A demand for next-generation oncolytic adenoviruses. Hermiston T Curr Opin Mol Ther; 2006 Aug; 8(4):322-30. PubMed ID: 16955695 [TBL] [Abstract][Full Text] [Related]
16. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Thorne SH; Contag CH Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic Virus-Driven Biotherapies from Bench to Bedside. Duan S; Wang S; Qiao L; Yu X; Wang N; Chen L; Zhang X; Zhao X; Liu H; Wang T; Wu Y; Li N; Liu F Small; 2023 Jun; 19(23):e2206948. PubMed ID: 36879416 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated cancer gene therapy and virotherapy (Review). Fukazawa T; Matsuoka J; Yamatsuji T; Maeda Y; Durbin ML; Naomoto Y Int J Mol Med; 2010 Jan; 25(1):3-10. PubMed ID: 19956895 [TBL] [Abstract][Full Text] [Related]
19. [Progress in using Newcastle disease virus for tumor therapy: a review]. Wu Y; Hao J; Li D Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1031-6. PubMed ID: 21090105 [TBL] [Abstract][Full Text] [Related]
20. [Oncolytic virus therapy for malignant brain tumors]. Ino Y; Todo T Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]